RESUMEN
BACKGROUND: In 2009, untargeted metabolomics led to the delineation of a new clinico-biological entity called cerebellar ataxia with elevated cerebrospinal free sialic acid, or CAFSA. In order to elucidate CAFSA, we applied sequentially targeted and untargeted omic approaches. METHODS AND RESULTS: First, we studied five of the six CAFSA patients initially described. Besides increased CSF free sialic acid concentrations, three patients presented with markedly decreased 5-methyltetrahydrofolate (5-MTHF) CSF concentrations. Exome sequencing identified a homozygous POLG mutation in two affected sisters, but failed to identify a causative gene in the three sporadic patients with high sialic acid but low 5-MTHF. Using targeted mass spectrometry, we confirmed that free sialic acid was increased in the CSF of a third known POLG-mutated patient. We then pursued pathophysiological analyses of CAFSA using mass spectrometry-based metabolomics on CSF from two sporadic CAFSA patients as well as 95 patients with an unexplained encephalopathy and 39 controls. This led to the identification of a common metabotype between the two initial CAFSA patients and three additional patients, including one patient with Kearns-Sayre syndrome. Metabolites of the CSF metabotype were positioned in a reconstruction of the human metabolic network, which highlighted the proximity of the metabotype with acetyl-CoA and carnitine, two key metabolites regulating mitochondrial energy homeostasis. CONCLUSION: Our genetic and metabolomics analyses suggest that CAFSA is a heterogeneous entity related to mitochondrial DNA alterations either through POLG mutations or a mechanism similar to what is observed in Kearns-Sayre syndrome.
Asunto(s)
Ataxia Cerebelosa/diagnóstico , Genómica/métodos , Metabolómica/métodos , Ácido N-Acetilneuramínico/líquido cefalorraquídeo , Tetrahidrofolatos/líquido cefalorraquídeo , Adulto , Estudios de Casos y Controles , Ataxia Cerebelosa/líquido cefalorraquídeo , Ataxia Cerebelosa/genética , Ataxia Cerebelosa/metabolismo , Análisis Mutacional de ADN , ADN Polimerasa gamma/genética , ADN Mitocondrial/análisis , Femenino , Humanos , Masculino , Espectrometría de Masas , Hermanos , Tetrahidrofolatos/análisis , Secuenciación del Exoma/métodosRESUMEN
OBJECTIVE: The purpose of this paper is to report a patient with otherwise unexplained cerebellar ataxia with serum antibodies against contactin-associated protein-2 (CASPR-2) and provide a detailed description of the composition of cellular infiltrates in the cerebrospinal fluid (CSF) compared to the peripheral blood (PB). CASPR-2 antibodies strongly labeling axons of cerebellar granule neurons have recently been identified in sera from nine patients with otherwise unexplained progressive cerebellar ataxia with mild to severe cerebellar atrophy. DESIGN: This is a report of a single case. METHODS: The study methods used were neurologic examination, magnetic resonance imaging, fluorodeoxyglucose positron emisson tomography, lumbar puncture and multicolor flow-cytometry. RESULTS: A 23-year-old Caucasian male presented with a two-year history of a progressive cerebellar and brainstem syndrome. Magnetic resonance imaging (MRI) showed pronounced cerebellar atrophy, especially of the medial parts of the hemispheres and the vermis. Cerebral fluorodeoxyglucose positron emission tomography (FDG-PET) showed pronounced hypometabolism of the whole cerebellum. CASPR-2 antibodies were detected in the serum but not the CSF, and none of the staging and laboratory assessments revealed other causes of progressive cerebellar degeneration. Interestingly, flow-cytometry of the CSF as compared to the PB showed increased fractions of CD138+ plasma cells as well as human leukocyte antigen (HLA)-DR+ CD8+ T cells suggesting that both B cells and CD8+ T cells were preferentially recruited to and activated within the CSF- (and putatively central nervous system (CNS)-) compartment. CONCLUSION: We confirm the association of CASPR-2 serum antibodies with cerebellar ataxia and provide the first evidence for a combined humoral and cellular immune response in this novel antibody-associated inflammatory CNS disease.
Asunto(s)
Autoanticuerpos/biosíntesis , Ataxia Cerebelosa/líquido cefalorraquídeo , Proteínas de la Membrana/inmunología , Proteínas del Tejido Nervioso/inmunología , Células Plasmáticas/metabolismo , Sindecano-1/líquido cefalorraquídeo , Linfocitos T Citotóxicos/metabolismo , Autoanticuerpos/líquido cefalorraquídeo , Ataxia Cerebelosa/diagnóstico , Ataxia Cerebelosa/inmunología , Humanos , Masculino , Proteínas de la Membrana/líquido cefalorraquídeo , Proteínas del Tejido Nervioso/líquido cefalorraquídeo , Células Plasmáticas/inmunología , Sindecano-1/inmunología , Linfocitos T Citotóxicos/inmunología , Adulto JovenRESUMEN
OBJECTIVES: Seizure-related 6 homolog like 2 (SEZ6L2) antibody-associated ataxia is an extremely rare disease. Six patients have been reported and none of them improved significantly with immunotherapy. Herein, we present the case of a patient with cerebellar ataxia and SEZ6L2 antibodies who benefited from immunotherapy, which dramatically altered the course of her disease. METHODS: We present a case report of a 73-year-old woman with progressive balance problems. Her condition had rapidly deteriorated in the 2 weeks before the admission to our hospital leading to repeated falls and eventually left her bed-ridden. RESULTS: She presented with severe trunk ataxia, bidirectional nystagmus, dysarthric speech, and persistent nausea. With the exception of cerebellar atrophy, extensive imaging studies revealed no pathology. SEZ6L2 antibodies were found in both CSF and serum. Over a period of 9 months, our patient received immunotherapy consisting of steroid pulse therapy, IV immunoglobulin infusions, rituximab, and cyclophosphamide. Consequently, her condition improved markedly, and she was discharged home from the neurologic rehabilitation unit. DISCUSSION: Our case report shows that intense sequential immunotherapy may considerably improve level of functioning in some patients with SEZ6L2 antibody-associated cerebellar ataxia. CLASSIFICATION OF EVIDENCE: This provides Class IV evidence. It is a single observational study without controls.
Asunto(s)
Ataxia Cerebelosa/tratamiento farmacológico , Ataxia Cerebelosa/inmunología , Factores Inmunológicos/farmacología , Proteínas de la Membrana/inmunología , Anciano , Ataxia Cerebelosa/sangre , Ataxia Cerebelosa/líquido cefalorraquídeo , Femenino , Humanos , InmunoterapiaRESUMEN
In order to identify new metabolic abnormalities in patients with complex neurodegenerative disorders of unknown aetiology, we performed high resolution in vitro proton nuclear magnetic resonance spectroscopy on patient cerebrospinal fluid (CSF) samples. We identified five adult patients, including two sisters, with significantly elevated free sialic acid in the CSF compared to both the cohort of patients with diseases of unknown aetiology (n = 144; P < 0.001) and a control group of patients with well-defined diseases (n = 91; P < 0.001). All five patients displayed cerebellar ataxia, with peripheral neuropathy and cognitive decline or noteworthy behavioural changes. Cerebral MRI showed mild to moderate cerebellar atrophy (5/5) as well as white matter abnormalities in the cerebellum including the peridentate region (4/5), and at the periventricular level (3/5). Two-dimensional gel analyses revealed significant hyposialylation of transferrin in CSF of all patients compared to age-matched controls (P < 0.001)--a finding not present in the CSF of patients with Salla disease, the most common free sialic acid storage disorder. Free sialic acid content was normal in patients' urine and cultured fibroblasts as were plasma glycosylation patterns of transferrin. Analysis of the ganglioside profile in peripheral nerve biopsies of two out of five patients was also normal. Sequencing of four candidate genes in the free sialic acid biosynthetic pathway did not reveal any mutation. We therefore identified a new free sialic acid syndrome in which cerebellar ataxia is the leading symptom. The term CAFSA is suggested (cerebellar ataxia with free sialic acid).
Asunto(s)
Ataxia Cerebelosa/líquido cefalorraquídeo , Ácido N-Acetilneuramínico/líquido cefalorraquídeo , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Atrofia/líquido cefalorraquídeo , Células Cultivadas , Ataxia Cerebelosa/patología , Cerebelo/patología , Niño , Preescolar , Estudios de Cohortes , Femenino , Humanos , Lactante , Imagen por Resonancia Magnética/métodos , Espectroscopía de Resonancia Magnética/métodos , Masculino , Persona de Mediana Edad , Transferrina/líquido cefalorraquídeoRESUMEN
Anti-glutamic acid decarboxylase autoantibodies (GAD-Abs) are found in some patients with cerebellar ataxia. We reported previously that CSF IgGs depress cerebellar GABAergic synaptic transmissions by a presynaptic mechanism. Using whole-cell recordings from rat cerebellar slices, we found in the present study that CSF IgG-induced depressive effects were abolished by absorption of GAD-Abs using recombinant GAD. Furthermore, forskolin, an activator of cAMP, recovered the CSF IgG-induced reduction of GABA release. Our results provide evidence that GAD-Abs in the CSF elicited physiopathological effects on cerebellar GABA synapses in vitro and that such synaptic impairment was reversible.
Asunto(s)
Cerebelo/citología , Glutamato Descarboxilasa/inmunología , Inmunoglobulina G/farmacología , Potenciales Postsinápticos Inhibidores/efectos de los fármacos , Sinapsis/efectos de los fármacos , Ácido gamma-Aminobutírico/metabolismo , Anciano , Animales , Animales Recién Nacidos , Ataxia Cerebelosa/líquido cefalorraquídeo , Ataxia Cerebelosa/inmunología , Colforsina/farmacología , Humanos , Inmunoglobulina G/líquido cefalorraquídeo , Técnicas In Vitro , Técnicas de Placa-Clamp/métodos , RatasRESUMEN
Lambert-Eaton myasthenic syndrome (LEMS) is an immune-mediated disorder of the neuromuscular junction that rarely is associated with cerebellar ataxia (CA). We describe two patients with non-paraneoplastic LEMS associated with CA who showed high levels of anti-P/Q-type voltage-gated calcium channels antibodies in the serum and cerebrospinal fluid, and reduced CMAP with increment after brief maximum voluntary contraction in electrophysiological studies. We suggest that LEMS should be considered in the differential diagnosis of patients with CA.
Asunto(s)
Ataxia Cerebelosa/complicaciones , Síndrome Miasténico de Lambert-Eaton/complicaciones , Potenciales de Acción/fisiología , Adulto , Anticuerpos/sangre , Canales de Calcio/inmunología , Ataxia Cerebelosa/sangre , Ataxia Cerebelosa/líquido cefalorraquídeo , Ataxia Cerebelosa/tratamiento farmacológico , Femenino , Humanos , Inmunoglobulinas Intravenosas/uso terapéutico , Síndrome Miasténico de Lambert-Eaton/sangre , Síndrome Miasténico de Lambert-Eaton/líquido cefalorraquídeo , Síndrome Miasténico de Lambert-Eaton/tratamiento farmacológico , Masculino , Persona de Mediana Edad , Músculo Esquelético/fisiopatología , Conducción Nerviosa/fisiología , Síndromes Paraneoplásicos/sangre , Síndromes Paraneoplásicos/complicacionesAsunto(s)
Ataxia Cerebelosa/diagnóstico , Ataxia Cerebelosa/virología , Infecciones por Virus de Epstein-Barr/complicaciones , Infecciones por Virus de Epstein-Barr/diagnóstico , Enfermedad Aguda , Adolescente , Ataxia Cerebelosa/líquido cefalorraquídeo , Diagnóstico Diferencial , Herpesvirus Humano 4/aislamiento & purificación , Humanos , MasculinoRESUMEN
Acute cerebellitis, also known as acute cerebellar ataxia, is a rare inflammatory syndrome characterized by cerebellar dysfunction. It typically occurs as a primary infectious, post-infectious or post vaccination disorder, typically in early childhood. The author presents a case of recurrent, acute cerebellar ataxia in a 20-year-old woman. In the described case the first event of acute cerebellar ataxia occured at the age of 15. The disease lasted 3 weeks and symptoms disappeared entirely. The similar symptoms recurred after 5 years but they were more pronounced and accompanied by pleocytosis, high protein level and low glucose level in cerebrospinal fluid. The symptoms disappeared entirely after 2 months of treatment.
Asunto(s)
Antibacterianos/uso terapéutico , Ataxia Cerebelosa/líquido cefalorraquídeo , Ataxia Cerebelosa/tratamiento farmacológico , Enfermedad Aguda , Adulto , Femenino , Humanos , Recurrencia , Resultado del TratamientoRESUMEN
Cerebrospinal fluid (CSF) amino acid neurotransmitters, related compounds, and their precursors, choline levels, and acetylcholinesterase activity were measured in the CSF of patients with cerebellar ataxia during a randomized, double-blind, crossover, placebo-controlled clinical trial of physostigmine salicylate. The CSF gamma-aminobutyric acid, methionine, and choline levels, adjusted for age, were significantly lower in patients with cerebellar ataxia compared with controls. Physostigmine selectively reduced the level of CSF isoleucine and elevated the levels of phosphoethanolamine. No change occurred in CSF acetylcholinesterase activity and in the levels of plasma amino compounds in patients with cerebellar ataxia when compared with controls. Median ataxia scores did not statistically differ between placebo and physostigmine nor did functional improvement occur in any of the patients.
Asunto(s)
Acetilcolina/líquido cefalorraquídeo , Aminoácidos/líquido cefalorraquídeo , Sistema Nervioso Central/metabolismo , Ataxia Cerebelosa/líquido cefalorraquídeo , Neurotransmisores/líquido cefalorraquídeo , Acetilcolinesterasa/líquido cefalorraquídeo , Adulto , Ataxia Cerebelosa/tratamiento farmacológico , Ataxia Cerebelosa/enzimología , Colina/líquido cefalorraquídeo , Método Doble Ciego , Humanos , Masculino , Persona de Mediana Edad , Fisostigmina/uso terapéutico , Ácido gamma-Aminobutírico/líquido cefalorraquídeoRESUMEN
BACKGROUND: Antibodies to glutamic acid decarboxylase (GAD-Ab) are described in patients with insulin-dependent (type 1) diabetes mellitus (IDDM), in stiff-man syndrome, and, recently, in a few patients with cerebellar ataxia. OBJECTIVES: To show a link between GAD-Ab and some patients with cerebellar ataxia and to clarify their clinical and immunologic profiles. METHODS: Serum samples were selected from 9000 samples of 4 laboratories. The selection criterion was an immunohistochemical pattern compatible with GAD-Ab that was confirmed by radioimmunoassay. We identified 22 patients with stiff-man syndrome and 14 with cerebellar ataxia and GAD-Ab. RESULTS: Thirteen of the 14 patients with cerebellar ataxia and GAD-Ab were women, and 11 had late-onset IDDM. Patients did not have clinical or radiologic evidence of brainstem involvement. Ten patients had oligoclonal IgG bands in the cerebrospinal fluid, and intrathecal GAD-Ab synthesis was observed in 5 of the 6 patients studied. The level of GAD-Ab of these patients was similar to those with stiff-man syndrome and significantly higher than those with IDDM or with polyendocrine autoimmunity (P<.001). However, the GAD-Ab levels of 6 of the 9 patients with polyendocrine autoimmunity overlapped with those of patients with cerebellar ataxia. CONCLUSIONS: These results suggest a link between high level of GAD-Ab and some cases of cerebellar ataxia, particularly women with IDDM. If high serum levels of GAD-Ab are detected, the cerebrospinal fluid should be evaluated for the presence of oligoclonal IgG bands and intrathecal synthesis of GAD-Ab to further prove an autoimmune origin of the syndrome.
Asunto(s)
Anticuerpos Antiidiotipos/sangre , Ataxia Cerebelosa/inmunología , Diabetes Mellitus Tipo 1/inmunología , Glutamato Descarboxilasa/inmunología , Inmunoglobulinas/sangre , Síndrome de la Persona Rígida/sangre , Adulto , Edad de Inicio , Anciano , Atrofia , Ataxia Cerebelosa/sangre , Ataxia Cerebelosa/líquido cefalorraquídeo , Cerebelo/patología , Diabetes Mellitus Tipo 1/sangre , Femenino , Glutamato Descarboxilasa/sangre , Glutamato Descarboxilasa/líquido cefalorraquídeo , Humanos , Inmunoglobulinas/líquido cefalorraquídeo , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Bandas OligoclonalesRESUMEN
BACKGROUND: Brain magnetic resonance imaging (MRI) findings during acute cerebellar ataxia in cases of postinfectious cerebellitis are frequently normal. This has resulted in the use of other imaging modalities, such as single-photon emission computed tomography, to aid diagnosis. OBJECTIVE: To illustrate the chronologic occurrence of cerebellar ataxia, abnormal findings on MRI, and cerebral spinal fluid pleocytosis in an adult case of postinfectious cerebellitis. METHODS: Case report. RESULTS: A patient with a 6-week history of occipital headaches and only mild tandem gait difficulty had abnormal MRI findings that were consistent with cerebellar inflammation. As cerebellar ataxia progressed in parallel with cerebral spinal fluid pleocytosis, MRI findings indicative of cerebellar inflammation resolved, while single-photon emission computed tomography showed cerebellar hyperperfusion. Recovery of neurologic function was accompanied by clearing of the pleocytosis and residual MRI-detected cerebellar atrophy. CONCLUSION: This case demonstrates that transient abnormalities can be detected by MRI before clinical manifestations of cerebellitis appear, while hyperperfusion detected by single-photon emission computed tomography is prolonged.
Asunto(s)
Ataxia Cerebelosa/patología , Enfermedades Cerebelosas/patología , Adulto , Ataxia Cerebelosa/líquido cefalorraquídeo , Ataxia Cerebelosa/diagnóstico por imagen , Enfermedades Cerebelosas/líquido cefalorraquídeo , Enfermedades Cerebelosas/diagnóstico por imagen , Cerebelo/diagnóstico por imagen , Femenino , Humanos , Recuento de Leucocitos , Leucocitosis/patología , Imagen por Resonancia Magnética , Tomografía Computarizada de Emisión de Fotón ÚnicoRESUMEN
Tissue and cultured cells of different species and embryological origins incubated with serum (diluted up to 10,000-fold) or cerebrospinal fluid (CSF) (6-fold dilution) from a 48-year-old female patient with idiopathic late-onset cerebellar ataxia, exhibited a bright specific perinuclear staining when studied by indirect immunofluorescence microscopy. The pattern of the staining was that characteristic of the Golgi apparatus, consisting of a crescent-shaped juxtanuclear reticulum located in the vicinity of the microtubule organizing center. Changes in location and organization of the organelle stained by the patient's serum during mitosis or after incubation of the cells with Colcemid, taxol or monensin, resulted in a disruption of the reticulum that followed the expected patterns for Golgi apparatus. The staining was specifically absorbed with Golgi cisternae-enriched membrane fractions. Finally, dot-immunoblotting studies of membrane and soluble fractions of Golgi cisternae and vesicles showed that the anti-Golgi antibody (AGA) reacted with the cytoplasmic domain of an integral membrane protein contained in the Golgi cisternae. The presence of this unusual autoantibody in an idiopathic late-onset cerebellar ataxia-bearing patient can afford some insights into the pathogenesis of these neurological diseases.
Asunto(s)
Autoanticuerpos/análisis , Ataxia Cerebelosa/sangre , Aparato de Golgi/inmunología , Ataxia Cerebelosa/líquido cefalorraquídeo , Femenino , Humanos , Glicoproteínas de Membrana/inmunología , Persona de Mediana EdadRESUMEN
gamma-Aminobutyric acid (GABA) was measured in CSF as such and following acid hydrolysis by the ion-exchange/fluorometric method. The conjugated GABA level was obtained by subtracting the free GABA level from the total GABA level. Results showed that at room temperature, while the free GABA level increased, the level of conjugated GABA decreased in a linear fashion during the first 24 h (r = -0.974; P less than 0.001). Aging and CSF conjugated GABA levels were inversely correlated (r = -0.613; P less than 0.05). Unlike free GABA levels, the levels of conjugated GABA were not altered in Huntington's disease, Parkinson's disease, cerebellar ataxias, dementias, epilepsy and multiple sclerosis compared to controls. In patients with Huntington's disease, on administration of isoniazid at 900 mg/day, along with pyridoxine at 100 mg/day, a 4-fold increase of both free (P less than 0.005) and conjugated GABA (P less than 0.0025) was seen. The results indicate that while total GABAergic peptides are not altered in several of the neurologic diseases studied, drugs such as isoniazid and/or pyridoxine can significantly elevate both free and conjugated GABA levels in human CSF.
Asunto(s)
Enfermedades del Sistema Nervioso/líquido cefalorraquídeo , Ácido gamma-Aminobutírico/líquido cefalorraquídeo , Adulto , Factores de Edad , Anciano , Ataxia Cerebelosa/líquido cefalorraquídeo , Demencia/líquido cefalorraquídeo , Epilepsia/líquido cefalorraquídeo , Humanos , Enfermedad de Huntington/líquido cefalorraquídeo , Isoniazida/farmacología , Masculino , Persona de Mediana Edad , Esclerosis Múltiple/líquido cefalorraquídeo , Enfermedad de Parkinson/líquido cefalorraquídeo , TemperaturaRESUMEN
Isoelectric focusing is a valuable method for the analysis of cerebrospinal fluid (CSF) proteins. Its high resolving power has, however, created problems in identifying the large number of protein bands separated. In an attempt to identify these bands, two-dimensional crossed immunoelectrofocusing has been used, where isoelectric focusing is combined with rocket immunoelectrophoresis. By these methods 9 of the normal proteins in the acidic pH interval have been identified. In addition the unusual CSF protein abnormalities occurring in Marie-Sanger-Brown's ataxia and alcoholic cerebellar degeneration have been shown to represent increases of different microheterogeneous forms of transferrin.
Asunto(s)
Proteínas del Líquido Cefalorraquídeo/análisis , Inmunoelectroforesis Bidimensional/métodos , Inmunoelectroforesis/métodos , Focalización Isoeléctrica/métodos , Alcoholismo/líquido cefalorraquídeo , Ataxia Cerebelosa/líquido cefalorraquídeo , HumanosRESUMEN
Evidence for immune activation was investigated in 12 patients with a rare syndrome of self-limiting, delayed onset cerebellar dysfunction following an attack of falciparum malaria which occurred 18-26 d previously. Concentrations of tumour necrosis factor, interleukin 6 and interleukin 2 were all significantly higher in serum samples of patients during cerebellar ataxia than in recovery sera and in the sera of 8 patients who did not develop delayed cerebellar dysfunction following an attack of falciparum malaria. Cytokine concentrations in the cerebrospinal fluid were also significantly higher in ataxic patients than in controls. These findings suggest that immunological mechanisms may play a role in delayed cerebellar dysfunction following falciparum malaria.
Asunto(s)
Malaria Cerebral/inmunología , Adolescente , Adulto , Ataxia Cerebelosa/sangre , Ataxia Cerebelosa/líquido cefalorraquídeo , Ataxia Cerebelosa/inmunología , Femenino , Humanos , Interleucina-2/análisis , Interleucina-6/análisis , Malaria Cerebral/sangre , Malaria Cerebral/líquido cefalorraquídeo , Masculino , Persona de Mediana Edad , Factor de Necrosis Tumoral alfa/análisisRESUMEN
We report a 9-year-old girl with cerebellar ataxia in whom the administration of thyrotropin-releasing hormone was effective in the treatment of a prolonged neurologic deficit. Ataxia persisted 18 months after its acute onset of unknown origin. Concentrations of homovanillic acid and 5-hydroxy-indoleacetic acid in the cerebrospinal fluid were measured repeatedly. Changes in the 5-hydroxy-indoleacetic/homovanillic acid ratio were observed, suggesting that thyrotropin-releasing hormone improved symptoms by influencing serotonin metabolism in the central nervous system.
Asunto(s)
Ataxia Cerebelosa/tratamiento farmacológico , Hormona Liberadora de Tirotropina/uso terapéutico , Ataxia Cerebelosa/líquido cefalorraquídeo , Niño , Femenino , Ácido Homovanílico/líquido cefalorraquídeo , Humanos , Ácido Hidroxiindolacético/líquido cefalorraquídeoRESUMEN
The authors describe the results of electrophoresis studies of 111 cerebrospinal fluids from 110 patients with various spinocerebellar degenerative diseases (58 cases of Friedreich's disease, 14 of Pierre-Marie's ataxia, 12 of Strumpell-Lorrain paraplegia, 23 cerebellar atrophies, and 4 cases of Roussy-Levy disease). The degenerative profile of the electrophoresis findings were characterized by an overall reduction in CSF proteins, an increase in pre-albumin, and a reduction in gammaglobulin, and this was noted in 82 cases (73.8 p. 100). Low levels (less than or equal to 0.17 g/l) of proteins were observed in 19 cases (17.1 p. 100), and increased pre-albumin in 43 cases (38.7 p. 100). Reduced gammaglobulin was present in 20 cases (18.0 p. 100), and the cerebrospinal fluid was normal in only 29 cases (26.1 p. 100). These modifications could result from a particular type of physiopathological process of cell degeneration in the nervous system.
Asunto(s)
Ataxia Cerebelosa/líquido cefalorraquídeo , Proteínas del Líquido Cefalorraquídeo/análisis , Atrofia/líquido cefalorraquídeo , Electroforesis en Gel de Agar , Electroforesis en Acetato de Celulosa , Ataxia de Friedreich/líquido cefalorraquídeo , Humanos , Paraplejía/líquido cefalorraquídeo , Prealbúmina/líquido cefalorraquídeo , gammaglobulinas/líquido cefalorraquídeoRESUMEN
Three patients aged 32, 30 and 36 years, had chicken pox then developed acute cerebellar ataxia (for two) and acute polyradiculoneuritis. Cerebrospinal fluid (CSF) protein content was increased and varicella virus serology was positive in both blood and CSF. All three patients improved with aciclovir.
Asunto(s)
Ataxia Cerebelosa/etiología , Varicela/complicaciones , Polirradiculopatía/etiología , Enfermedad Aguda , Adulto , Ataxia Cerebelosa/líquido cefalorraquídeo , Ataxia Cerebelosa/virología , Proteínas del Líquido Cefalorraquídeo/análisis , Varicela/líquido cefalorraquídeo , Herpesvirus Humano 3/aislamiento & purificación , Humanos , Masculino , Polirradiculopatía/líquido cefalorraquídeo , Polirradiculopatía/virologíaRESUMEN
A four-year-old boy presented with moderate ataxia triggered by a minor head trauma several weeks ago. Discrepantly severe signal changes of cerebral white matter with almost CSF-isointense signal on all pulse sequences were detected at cranial MRI. Localized proton MR spectroscopy of cerebral white matter demonstrated an even decrease of all metabolites. Glycine was found elevated in CSF. This pattern of clinical history, MR imaging and spectroscopy features and elevated glycine in CSF is characteristic for a novel entity amongst the leukoencephalopathies of childhood. It was originally termed "myelinopathia centralis diffusa" and renamed "vanishing white matter disease" later.
Asunto(s)
Encefalopatías/diagnóstico , Encefalopatías/líquido cefalorraquídeo , Ataxia Cerebelosa/líquido cefalorraquídeo , Ataxia Cerebelosa/diagnóstico , Preescolar , Enfermedades Desmielinizantes/líquido cefalorraquídeo , Enfermedades Desmielinizantes/diagnóstico , Diagnóstico Diferencial , Humanos , Leucoencefalopatía Multifocal Progresiva/líquido cefalorraquídeo , Leucoencefalopatía Multifocal Progresiva/diagnóstico , Imagen por Resonancia Magnética , Espectroscopía de Resonancia Magnética , MasculinoRESUMEN
IMPORTANCE: Progressive multifocal leukoencephalopathy results from lytic infection of the glia by the JC polyomavirus (JCV); JCV granule cell neuronopathy is caused by infection with a mutated form of JCV, leading to a shift in viral tropism from the glia to cerebellar granule cells. This shift results in a clinical syndrome dominated by progressive cerebellar dysfunction that might elude standard diagnostic workup strategies for ataxia. OBSERVATIONS: We present the case report of a patient receiving long-term rituximab therapy who developed progressive cerebellar ataxia and marked isolated cerebellar degeneration. This syndrome resulted from JCV granule cell neuronopathy associated with a novel JCV mutation. CONCLUSIONS AND RELEVANCE: New onset or worsening of isolated cerebellar ataxia in patients being treated with rituximab or natalizumab warrants early assessment for JCV infection.